Your browser doesn't support javascript.
loading
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.
Dryden, Murray; Mudara, Caroline; Vika, Caroline; Blumberg, Lucille; Mayet, Natalie; Cohen, Cheryl; Tempia, Stefano; Parker, Arifa; Nel, Jeremy; Perumal, Rubeshan; Groome, Michelle J; Conradie, Francesca; Ndjeka, Norbert; Sigfrid, Louise; Merson, Laura; Jassat, Waasila.
Affiliation
  • Dryden M; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa. Electronic address: murray.dryden@live.co.za.
  • Mudara C; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Vika C; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Blumberg L; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.
  • Mayet N; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa.
  • Cohen C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Tempia S; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Parker A; Divisions of General Medicine and Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
  • Nel J; Department of Medicine, Division of Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Perumal R; South African Medical Research Council-CAPRISA HIV-Tuberculosis Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Groome MJ; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Conradie F; Clinical HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Ndjeka N; Drug-Resistant Tuberculosis, Tuberculosis & HIV Directorate, National Department of Health, Pretoria, South Africa and University of KwaZulu-Natal, Durban, South Africa.
  • Sigfrid L; Global Support Centre, International Severe Acute Respiratory and emerging Infections Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Merson L; Pandemic Sciences Centre, International Severe Acute Respiratory and emerging Infections Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Jassat W; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.
Lancet Glob Health ; 10(9): e1247-e1256, 2022 09.
Article in En | MEDLINE | ID: mdl-35961348
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Lancet Glob Health Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Lancet Glob Health Year: 2022 Type: Article